When are genes a blueprint for cancer?

A free public lecture on the latest on our understanding of the role genes play in cancer, and the therapies being developed to fight it at the genetic level, at the Cancer Therapy & Research Center at The University of Texas Health Science Center

6 – 7:30 p.m. Thursday, January 12, 2012

CTRC, 7979 Wurzbach, 4th Floor Grossman Building, San Antonio


  • Gail Tomlinson, M.D., Ph.D., professor of pediatrics and interim director of the Greehey Children’s Cancer Research Institute (GCCRI)
    Family History: How your genes influence your risk of cancer
  • Patricia Dahia, M.D., Ph.D., associate professor of hematology and medical oncology
    Discovering genetic causes of cancer
  • Tim Huang, Ph.D., professor and chair of the department of molecular biology and CTRC deputy director
    Why genes don’t tell us everything: how epigenetics affects risk
  • Sunil Sudarshan, M.D., assistant professor of urology
    The metabolism of cancer
  • Robin Leach, Ph.D., professor in the department of cellular and structural biology and urology
    Using genes to predict cancer progression

For more information, call 210-450-1152. Sponsored by H-E-B and the Institute for the Integration of Medicine and Science at the UT Health Science Center San Antonio.

The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.

Share This Article!